These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 9103463

  • 21. Urinary soluble CD14 mediates human proximal tubular epithelial cell injury induced by LPS.
    Bussolati B, David S, Cambi V, Tobias PS, Camussi G.
    Int J Mol Med; 2002 Oct; 10(4):441-9. PubMed ID: 12239591
    [Abstract] [Full Text] [Related]

  • 22. Surfactant protein a inhibits lipopolysaccharide-induced immune cell activation by preventing the interaction of lipopolysaccharide with lipopolysaccharide-binding protein.
    Stamme C, Müller M, Hamann L, Gutsmann T, Seydel U.
    Am J Respir Cell Mol Biol; 2002 Sep; 27(3):353-60. PubMed ID: 12204898
    [Abstract] [Full Text] [Related]

  • 23. Membrane-anchored forms of lipopolysaccharide (LPS)-binding protein do not mediate cellular responses to LPS independently of CD14.
    Tapping RI, Orr SL, Lawson EM, Soldau K, Tobias PS.
    J Immunol; 1999 May 01; 162(9):5483-9. PubMed ID: 10228028
    [Abstract] [Full Text] [Related]

  • 24. A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood.
    de Haas CJ, van der Tol ME, Van Kessel KP, Verhoef J, Van Strijp JA.
    J Immunol; 1998 Oct 01; 161(7):3607-15. PubMed ID: 9759883
    [Abstract] [Full Text] [Related]

  • 25. Lipopolysaccharide is transferred from high-density to low-density lipoproteins by lipopolysaccharide-binding protein and phospholipid transfer protein.
    Levels JH, Marquart JA, Abraham PR, van den Ende AE, Molhuizen HO, van Deventer SJ, Meijers JC.
    Infect Immun; 2005 Apr 01; 73(4):2321-6. PubMed ID: 15784577
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Detection and biochemical characteristics of the receptor for complexes of soluble CD14 and bacterial lipopolysaccharide.
    Vita N, Lefort S, Sozzani P, Reeb R, Richards S, Borysiewicz LK, Ferrara P, Labéta MO.
    J Immunol; 1997 Apr 01; 158(7):3457-62. PubMed ID: 9120307
    [Abstract] [Full Text] [Related]

  • 31. Preparation and characterization of truncated human lipopolysaccharide-binding protein in Escherichia coli.
    Kohara J, Tsuneyoshi N, Gauchat JF, Kimoto M, Fukudome K.
    Protein Expr Purif; 2006 Oct 01; 49(2):276-83. PubMed ID: 16839777
    [Abstract] [Full Text] [Related]

  • 32. LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells.
    Blais DR, Vascotto SG, Griffith M, Altosaar I.
    Invest Ophthalmol Vis Sci; 2005 Nov 01; 46(11):4235-44. PubMed ID: 16249503
    [Abstract] [Full Text] [Related]

  • 33. Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome.
    Martin TR, Rubenfeld GD, Ruzinski JT, Goodman RB, Steinberg KP, Leturcq DJ, Moriarty AM, Raghu G, Baughman RP, Hudson LD.
    Am J Respir Crit Care Med; 1997 Mar 01; 155(3):937-44. PubMed ID: 9117029
    [Abstract] [Full Text] [Related]

  • 34. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14.
    Tobias PS, Soldau K, Gegner JA, Mintz D, Ulevitch RJ.
    J Biol Chem; 1995 May 05; 270(18):10482-8. PubMed ID: 7537731
    [Abstract] [Full Text] [Related]

  • 35. Regulation of interactions of endotoxin with host cells.
    Gioannini TL, Teghanemt A, Zarember KA, Weiss JP.
    J Endotoxin Res; 2003 May 05; 9(6):401-8. PubMed ID: 14733729
    [Abstract] [Full Text] [Related]

  • 36. Lipopolysaccharide-binding protein down-regulates the expression of interleukin-6 by human gingival fibroblast.
    Ren L, Leung WK, Loo TW, Jin L.
    J Periodontal Res; 2005 Oct 05; 40(5):407-16. PubMed ID: 16105094
    [Abstract] [Full Text] [Related]

  • 37. Endotoxin-neutralizing capacity of soluble CD14 is a highly conserved specific function.
    Grunwald U, Krüger C, Schütt C.
    Circ Shock; 1993 Mar 05; 39(3):220-5. PubMed ID: 7680967
    [Abstract] [Full Text] [Related]

  • 38. The molecular basis for therapeutic concepts utilizing CD14.
    Stelter F, Bernheiden M, Menzel R, Witt S, Jack RS, Grunwald U, Fan X, Schütt C.
    Prog Clin Biol Res; 1998 Mar 05; 397():301-13. PubMed ID: 9575571
    [Abstract] [Full Text] [Related]

  • 39. Screening of mimetic peptides for CD14 binding site with LBP and antiendotoxin activity of mimetic peptide in vivo and in vitro.
    Xu Z, Qian GS, Li Q, Feng QJ, Wu GM, Li KL.
    Inflamm Res; 2009 Jan 05; 58(1):45-53. PubMed ID: 19115038
    [Abstract] [Full Text] [Related]

  • 40. Reactivity of murine and human recombinant LPS-binding protein (LBP) within LPS and gram negative bacteria.
    Lengacher S, Jongeneel CV, Le Roy D, Lee JD, Kravchenko V, Ulevitch RJ, Glauser MP, Heumann D.
    J Inflamm; 2009 Jan 05; 47(4):165-72. PubMed ID: 9144073
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.